|
Re: Zenith-Oncology Pipeline
|
4
|
Zenith Epigenetics
|
Mar 23, 2021 02:24PM
|
|
Re: We should get financials this week
|
2
|
Resverlogix Corp.
|
Mar 22, 2021 11:46PM
|
|
Re: We should get financials this week
|
5
|
Resverlogix Corp.
|
Mar 22, 2021 12:39PM
|
|
Re: We should get financials this week
|
2
|
Resverlogix Corp.
|
Mar 22, 2021 11:25AM
|
|
Re: We should get financials this week
|
6
|
Resverlogix Corp.
|
Mar 21, 2021 03:37PM
|
|
Re: Zenith-Oncology Pipeline
|
6
|
Zenith Epigenetics
|
Mar 18, 2021 04:01PM
|
|
Re: Volume
|
3
|
Resverlogix Corp.
|
Mar 15, 2021 11:25AM
|
|
Re: Resverlogix Announces Change in Fiscal Year-End to December 31
|
2
|
Resverlogix Corp.
|
Mar 14, 2021 06:05PM
|
|
Re: Resverlogix Announces Change in Fiscal Year-End to December 31
|
3
|
Resverlogix Corp.
|
Mar 14, 2021 02:27PM
|
|
Re: RVX on local Calgary CTV at 5 and 6pm on 11 March
|
4
|
Resverlogix Corp.
|
Mar 12, 2021 10:16AM
|
|
Re: Local TV Station Global Calgary
|
5
|
Resverlogix Corp.
|
Mar 12, 2021 01:12AM
|
|
Re: Promissory Note
|
1
|
Zenith Epigenetics
|
Mar 10, 2021 01:17PM
|
|
Promissory Note
|
6
|
Zenith Epigenetics
|
Mar 09, 2021 04:20PM
|
|
Re: Yes , it seems like a hundred years ago...
|
5
|
Resverlogix Corp.
|
Mar 08, 2021 12:14PM
|
|
Re: Alberta
|
8
|
Resverlogix Corp.
|
Mar 04, 2021 12:29PM
|
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
9
|
Resverlogix Corp.
|
Mar 03, 2021 11:20AM
|
|
Re: rumours have been flying around the last ...
|
8
|
Zenith Epigenetics
|
Mar 01, 2021 01:00PM
|
|
Exempt Distribution
|
8
|
Zenith Epigenetics
|
Feb 17, 2021 02:51PM
|
|
Exempt Distribution
|
8
|
Resverlogix Corp.
|
Feb 17, 2021 02:42PM
|
|
Re: Rough Transcript - RVX Confernce Call - 02/04/2021
|
2
|
Resverlogix Corp.
|
Feb 14, 2021 05:56PM
|
